Key result
This article reviews the pathophysiology, diagnosis, management, prognosis, and nursing implications of peripartum cardiomyopathy, a rare and potentially lethal cardiac complication of pregnancy.
This article provides a comprehensive review of peripartum cardiomyopathy, including its pathophysiology, diagnosis, management, and nursing implications.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to peripartum cardiomyopathy risks; leaves open need for prospective management trials.
Peripartum cardiomyopathy is a rare and potentially lethal cardiac complication of pregnancy occurring in the final month of pregnancy through the first 5 months after birth. It is characterized by the development of congestive heart failure and left ventricular systolic dysfunction, in previously healthy women with no other identifiable cause for heart failure. The etiology of peripartum cardiomyopathy is not well understood. Potential causal mechanisms include infection, autoimmune disease, and abnormal response to the hemodynamic stresses of pregnancy. There is significant risk of reoccurrence in subsequent pregnancies. The purpose of this article is to review the pathophysiology, diagnosis, management, prognosis, and nursing implications of peripartum cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Denise Gagnon Palmer (2006) conducted a review in Peripartum cardiomyopathy. This article reviews the pathophysiology, diagnosis, management, prognosis, and nursing implications of peripartum cardiomyopathy, a rare and potentially lethal cardiac complication of pregnancy.
Synapse has enriched 10 related papers. Consider them for comparative context: